Colon cancer: Curcumin activates tumour suppressive signalling pathway

26 May 2023
Colon cancer: Curcumin activates tumour suppressive signalling pathway

Colorectal cancer is one of the most common types of cancer worldwide.

In over half of all cases, an important protective mechanism in cells is inactivated by mutations – the tumour suppressor gene p53.

The product of this gene, a transcription factor, induces a microRNA molecule called miR-34, which plays a critical role in tumour suppression.

A team led by Heiko Hermeking, Professor of Experimental and Molecular Pathology at LMU, has now demonstrated in cell cultures and in a mouse model that curcumin, a natural substance found in the spice turmeric, can bridge this silenced protective mechanism by activating an alternative, specific signalling pathway that induces the expression of miR-34.

“There were already indications in the literature that curcumin can induce miR-34,” says Hermeking, “but there was no systematic investigation of the phenomenon before now. Moreover, it was unclear what mechanism could be behind it.”

Using genetically-modified human colorectal cancer cell lines, the researchers have now demonstrated that curcumin increases the production of so-called reactive oxygen species (ROS) in tumour cells.

These ROS activate a signalling pathway that leads to the production of miR-34 via the transcription factor NRF2 – which then induces premature ageing of the tumour cells and programmed cell death.

“Furthermore, the ability of tumour cells to migrate and invade into surrounding tissue is impaired,” says Hermeking.

“We were also able to confirm in our mouse model that the curcumin-induced expression of miR-34 suppresses the metastasis of colorectal cancer cells into the lung.”

In addition, curcumin made tumour cells more sensitive to the chemotherapeutic substance 5-FU by means of miR-34.

An important aspect of the results is that these effects are independent of p53, which is often lost in the majority of tumour types and would be difficult to reconstitute in all tumour cells.

“With curcumin, we’ve found a substance with which we could intervene in the signal cascade beneath p53 by activating miR-34,” says Hermeking.

According to the authors, the results of the study could give rise to interesting approaches for new therapeutic options, which should be pursued in further studies.

Source: Ludwig-Maximilians-Universität München